Could a tiny sensor spare newborns dozens of needle sticks?

NCT ID NCT04386005

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

Newborns at risk for low blood sugar (hypoglycemia) currently undergo frequent heel-stick blood tests, which can be painful. This study tests whether a continuous glucose monitor (CGM) placed on the thigh can safely and accurately track glucose levels with far fewer needle sticks. The Dexcom G7 sensor, already approved for older children and adults, will be used in about 50 at-risk newborns to see if it is feasible, precise, and acceptable to parents and nurses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexcom G7 continuous glucose monitor
What this could lead to
If successful, this could lead to a less painful way to monitor blood sugar in newborns at risk for hypoglycemia, reducing needle sticks and catching more low-glucose episodes.
What could go wrong
This is a small feasibility study, not yet testing clinical outcomes. The device is not FDA-approved for newborns, and its accuracy in this population is unproven. Skin irritation or inaccurate readings remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL HYPOGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Penn State Health Milton S Hershey Medical Center

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.